Prot# C15003: An Open Label, Dose Escalation, Phase 1 Study of MLN4924, a Novel Inhibitor of Nedd8-Activating Enzyme, in Adult Patients with Acute Myelogenous Leukemia, High-Grade Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia

Project: Research project

Project Details

StatusFinished
Effective start/end date6/17/116/17/14

Funding

  • Millennium Pharmaceuticals, Inc (C15003)